著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Motohiro Tamiya and Akihiro Tamiya and Kazutaka Hosoya and Yoshihiko Taniguchi and Toshihide Yokoyama and Yasushi Fukuda and Katsuya Hirano and Hirotaka Matsumoto and Ryota Kominami and Hidekazu Suzuki and Tomonori Hirashima and Junji Uchida and Mitsunori Morita and Masaki Kanazu and Nobuhiko Sawa and Yoshinori Kinoshita and Satoshi Hara and Toru Kumagai and Daichi Fujimoto,Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001),Investigational New Drugs,0167-6997,Springer Science and Business Media LLC,2019-08-07,37,6,1266-1273,https://cir.nii.ac.jp/crid/1360298759831745536,https://doi.org/10.1007/s10637-019-00843-y